Microvolt T-wave alternans during exercise and pacing are not comparable

Europace

Volumn 11, Issue 10, 2009, Pages 1375-1380

  Kraaier, Karin ^a   Verhorst, Patrick M J ^a   Van Der Palen, Job ^a   Van Dessel, Pascal F H M ^a   Wilde, Arthur A M ^b   Scholten, Marcoen F ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Implantable cardioverter defibrillator; Ischaemic cardiomyopathy; Risk stratification; Sudden cardiac death; T wave alternans

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; EXERCISE TEST; FEMALE; HEART ATRIUM PACING; HEART VENTRICLE PACING; HUMAN; ISCHEMIC HEART DISEASE; MALE; MICROVOLT T WAVE ALTERNANS; PRIORITY JOURNAL; T WAVE AMPLITUDE;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70349503688     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup253     Document Type: Article

References (23)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890
6. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
7. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol 2002;13:502-512
8. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 2005;46:75-82.
9. American Food and Drug Administration. http://www.fda.gov/cdrh/pdf5/ K050225 .pdf (10 March 2009).
10. Cutler MJ, Rosenbaum DS, Dunlap ME. Structural and electrical remodeling as therapeutic targets in heart failure. J Electrocardiol 2007;40:S1-7.
11. Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 2006;47:269-281
12. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006; 47 :456-463
13. Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 2008;52:1607-1615
14. Raatikainen MJ, Jokinen V, Virtanen V, Hartikainen J, Hedman A, Huikuri HV. Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol 2005;28:S193-7.
15. Richter S, Duray G, Hohnloser SH. How to analyze T-wave alternans. Heart Rhythm 2005;2:1268-1271
16. Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ et al. 'Indeterminate' microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006;48:1399-1404
17. Chan PS, Bartone C, Booth T, Kereiakes D, Chow T. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am Heart J 2007;153:523-529
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
19. Hohnloser SH, Klingenheben T, Zabel M, Li YG, Albrecht P, Cohen RJ. T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol 1997;8:987-993
20. Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang S, Peters RW et al. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002;13:845-850
21. Shalaby AA, Voigt A, El-Saed A, Mains M, Shusterman V. Microvolt T-wave alter-nans during atrial and ventricular pacing. Pacing Clin Electrophysiol 2007;30: S178-82.
22. Zacks ES, Morin DP, Ageno S, Janik M, Mauer AC, Markowitz SM et al. Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. Am Heart J 2007;153:392-397 (Pubitemid 46331827)
23. Groh WJ, Shinn TS, Engelstein EE, Zipes DP. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol 1999;10:1335-1339